Antiviral agent comprising CD4 and H2 histone
US5714462A · kind A · utility
2Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 30, 1994 |
| Grant date | Feb 3, 1998 |
| Priority date | — |
| Expiry date | Dec 30, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/838
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides an agent against HIV and/or related viruses, comprising CD4 or a CD4-like substance and an H2 histone or an H2 histone-like protein. The content of the CD4 or CD4-like substance is preferably less than the antivirally effective dose of that substance alone. The invention also provides an H2 histone or an H2-like protein, for use in a method of medical treatment, in particular against HIV and/or related viruses, and also for use in the manufacture of a pharmaceutical composition against HIV and/or related viruses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.